602
Agranulocytosis is a rare adverse effect associated with prolonged vancomycin therapy, and is potentially serious, especially in end stage renal disease (ESRD) patients.
 end stage renal disease (ESRD) patients: Subject; Agranulocytosis: Effect; prolonged vancomycin therapy: Treatment; prolonged: Treatment.Duration; vancomycin: Treatment.Drug; end stage renal disease (ESRD): Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 end stage renal disease (ESRD) patients: Subject; Agranulocytosis: Effect; prolonged vancomycin therapy: Treatment; prolonged: Treatment.Duration; vancomycin: Treatment.Drug; end stage renal disease (ESRD): Treatment.Disorder